According to the agreement, Lupin is granted semi-exclusive rights to co-promote the product in India using the LINVAS brand. Zydus has introduced the drug with the brand names Lipaglyn and Bilypsa and will maintain its marketing efforts for these products.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment